Vol 41, Issue 6

Additionally, 27% of US adults have reported they have a disability across a spectrum of areas.

Recent research found approximately 60 documented cases of suicidal ideation and 7 suicide attempts associated with semaglutide use in patients.

In this CME article, read more about best practices for utilizing clozapine plasma levels and the clozapine/norclozapine ratio to monitor clozapine therapy.

Cannabis withdrawal syndrome impacts approximately half of those who use it regularly. How can you help patients cease cannabis use?

Review tapering challenges and strategies for benzodiazepines in this Special Report article.

Check out the latest results from the phase 3 CONNEX-X study.

In this Special Report, get the latest from the American Psychiatric Association Annual Meeting!

What is their comparative safety?

"Hear the story of wood, cut and stained and carved for someone’s need."

Recent research sheds light on which antidepressants should be preferred as a first option for long-term use.

Transgender individuals are 4 times as likely as their cisgender peers to have a mental illness. Check out these culturally competent care strategies and tips to provide the best possible care.

The Psychiatric Times Editor-in-Chief discusses the clinical uses and casual prescribing of ketamine for the treatment of psychiatric disorders.

We're highlighting issues in addiction in our special Digital Supplement! Learn more here.

An expert discusses how the risks of benzodiazepine prescribing have been exaggerated in the minds of government officials, critics, and the public at large.

Physician-assisted suicide is now legal in 11 jurisdictions in the US. To this, several clinicians say: “We must care for the dying, not make them dead.” Learn more in our June cover story.